Autoimmune Hepatitis - liverfoundation.org · Autoimmune Hepatitis Maricruz Crespo, M.D. Pediatric...
Transcript of Autoimmune Hepatitis - liverfoundation.org · Autoimmune Hepatitis Maricruz Crespo, M.D. Pediatric...
Autoimmune Hepatitis
Maricruz Crespo, M.D.
Pediatric Gastroenterology, Hepatology & Nutrition
Assistant Professor, Pediatrics - CWRU School of Medicine
Disclosures
• None
2
Objectives
• To define autoimmune hepatitis
• To review diagnosis and management of autoimmune hepatitis
• To introduce new therapies
3
4
Autoimmune Disorder
5
Immune
System
Protects you from
diseases
6
http://greaterorlandogi.com/services/cirrhosis/
Definition
• Progressive inflammatory disease characterized by increased
serum IgG, presence of auto-antibodies and histological liver
changes
7
Etiology
Environmental Trigger
Genetic predisposition
Activation of the immune system with progression of inflammation and
development fibrosis
8
-Viruses
-Medications
-Other disease
Autoimmune Hepatitis (AIH)
• Type I
• Type II or Anti-LKM-1
• Overlap syndrome : AIH + primary sclerosing cholangitis
9
Subtypes
• Type I
– Most common type in the United States
– Has a female predominance
– Responds well to corticosteroids.
– Presence of antinuclear antibody (ANA) and anti-smooth muscle
antibody (ASMA)
10
• Type II
– 4% of the AIH cases in North America are type II
– Most common type in Europe
– Patients tend to be younger
– Poor response to corticosteroids
– Presence of anti-liver kidney microsomal antibody type 1 (anti-
LKM1) and/or anti-liver cytosol type 1 (anti-LC1) autoantibodies
11
Clinical presentation
• Asymptomatic, progressive, or fulminant
• Fatigue, intermittent jaundice, right upper quadrant pain, joint pain,
amenorrhea, nausea, vomiting
• Hepatitis, fulminant liver failure, portal hypertension, cirrhosis
• Presence of other autoimmune diseases: thyroiditis, Type 1 DM,
vitiligo, inflammatory bowel disease
12
Diagnosis
• Liver enzymes tests
• Absence of viral hepatitis markers
• Abnormal levels of serum globulins
• Presence of 1 or more auto-antibodies
• Liver histologic findings
13
Liver histology
14
Interface hepatitis
Therapeutic goal
• Induce remission – reducing inflammation and preventing to
progression into fibrosis/cirrhosis
• Maintenance of remission: biochemical and histological
• Possible withdrawal of therapy – after 2-3 years of normal
biochemical profile and normal liver biopsy
• Monitoring for other co-morbidities: bone disease, behavioral
problems, viral hepatitis (HAV, HBV)
15
Treatment: Induction and Maintenance
• Corticosteroids: 2mg/kg/d up to 60mg
– Tapering by 0.1-0.2mg/kg over 6-8 weeks
• Azathioprine: 1-2mg/kg day
– +/- low dose corticosteroids
• Liver transplant
– Acute liver failure
– Failure to treatment
16
Alternative Therapies
• Mycophenilate mofetil
• For patients with intolerance to azathioprine or have thiopurine
methyltransferase (TPMT) deficiency
• Budesonide
• Steroid with first pass metabolism in the liver
• Limits side effects
17
Budesonide versus Prednisone with Azathioprine for the Treatment of
Autoimmune Hepatitis in Children and Adolescents
Marek Woynarowski, MD1, Antal Nemeth, MD2, Yaacov Baruch, MD3, Sibylle Koletzko, MD4, Michael Melter, MD5,
Burkhard Rodeck, MD6, Christian P. Strassburg, MD7, Markus Pr€ols, MD8, Ma1gorzata Wozniak, MD1,
and Michael P. Manns, MD7, on behalf of the European Autoimmune Hepatitis-Budesonide Study Group*
18
• Budesonide not superior to prednisone in achieving
complete and biochemical remission
• For children with severe steroid-induced side effects,
budesonide treatment should be considered as
amaintenance therapy
Prognosis
• Histological resolution might take years (80% of patient with AIH
type I reach remission by 3 years)
• Patient with type II AIH rarely are unable to discontinue therapy
• 50-80% relapse rate in those patients with histological remission
that decide to discontinue medications
• 10-15% of pediatric patients with AIH undergo liver transplantation
by years of age
19
Post-Liver transplant AIH
• The recurrence rate of AIH following liver transplant isestimated to
be between 17%-42% at 5y period
• Generally, recurrent AIH in the transplanted liver responds well to
treatment by increasing immunosuppression or adding a
corticosteroids
20
Neuberger et al. World J Gatroenterology 2008; 14:3388
Overlap Syndrome
• Some patients have features of AIH but also have characteristics of
Primary Sclerosing Cholangitis or primary biliary cirrhosis
21
Primary Sclerosing Cholangitis
• Chronic disease that damages the bile duct
• Could also be present in patient with Inflammatory Bowel Disease
• Bile duct can become blocked secondary to inflammation or fibrosis
• Diagnosed by ragiological imaging
• There is no current treatment but sometimes patients could
undergo surgery to improve bile flow
22
In summary…
• AIH presentation ranges from silent disease to acute liver failure
• There is good response to therapy. Current mainstay therapy is
corticosteroid to induce remission and AZA +/- steroids for
maintenance therapy. Budesonide could be used on those patients
who do not tolerate corticosteroids
• Recurrence of the disease is possible in transplant recipeints
23
Thank You
24
Ask the Experts Patient Education Program
Reinaldo Garcia MD / Akron Children’s Hospital
12/08/2016
Ask the Experts: Pediatric Liver Disease
Patient Education Program
Cirrhosis and Portal Hypertension
Ask the Experts Patient Education Program
Cirrhosis
• Cirrhosis is a condition in which the liver does not function properly due to long-term damage
• The first known description of the condition is by Hippocrates in the 5th century BCE. The word cirrhosis is from Greek: κίρρωσις; kirrhosκιρρός "yellowish" and -osis (-ωσις) meaning "condition"
Ask the Experts Patient Education Program
• Cirrhosis could be caused by multiple medical conditions
• Typically, the disease comes on slowly over months or years
• Early on, there are often no symptoms
Ask the Experts Patient Education Program
Common causes of Cirrhosis in kidsMetabolic Alpha 1 antitrypsin deficiency
Cystic fibrosisGalactosemia
Infectious Hepatitis B and CCMVRubella
Inflammatory Autoimmune hepatitisPSC
Biliary Biliary atresiaCongenital hepatic fibrosis
Vascular lesions Budd-ChiariCongestive heart failure
Toxic Hypervitaminosis ATPNMalnutrition
Idiopathic Byler’s diseaseNeonatal hepatitis
Ask the Experts Patient Education Program
• As the disease worsens, a person may become tired, weak, itchy, have swelling in the lower legs, develop yellow skin, bruise easily (signs of liver dysfunction)
• Or have fluid build up in the abdomen, or develop spider-like blood vessels on the skin (signs of portal hypertension)
Ask the Experts Patient Education Program
Portal hypertension
• Portal hypertension is hypertension (high blood pressure) in the hepatic portal system (liver veins)
• which is composed of the portal vein and its branches that comes from the stomach, intestine, spleen and pancreas
Ask the Experts Patient Education Program
• In clinical practice the pressure is not measured
• Usually, doctors make the diagnosis of portal hypertension based on the presence of enlarge spleen, ascites or dilated veins or varices as seen during a physical exam of the abdomen or the anus
• Various lab tests, X-ray tests, and endoscopic exams may also be used
Ask the Experts Patient Education Program
Signs and symptoms of portal hypertension
• Ascites (free fluid in the peritoneal cavity)
• Dilated veins in the anterior abdominal wall
• Splenomegaly (enlarge spleen)
• Abdominal tenderness(Spontaneous bacterial peritonitis presents as complication)
• Portal hypertension increases the risk of hemorrhoids
• Esophageal varices and hematemesis (vomiting blood)
Ask the Experts Patient Education Program
The causes for portal hypertension
• Prehepatic causes include portal vein thrombosis or congenital atresia
• Intrahepatic causes include liver cirrhosis, hepatic fibrosis, and noncirrhotic causes
• Posthepatic obstruction occurs at any level between liver and right heart, including hepatic vein thrombosis, and constrictive pericarditis
Ask the Experts Patient Education Program
Ask the Experts Patient Education Program
The treatment of portal hypertension
• Prevention and management of bleedingFrom the esophageal varices
• Portosystemic shuntsTo reduce portal system pressure
• Treatment of ascites
• Treatment and prevention of hepatic encephalopathyconfusion and forgetfulness caused by poor liver function
Ask the Experts Patient Education Program
• Prevention of bleeding (prophylaxis) – Both pharmacological (non-
specific β-blockers, nitrate isosorbide mononitrate, vasopressin such as terlipressin)
– and endoscopic (banding ligation) treatment
• The management of active variceal bleeding– vasoactive drugs (somatostatin,
octreotide),– endoscopic banding ligation
(sometimes sclerotherapy) – balloon tamponade – and TIPS
Ask the Experts Patient Education Program
Portosystemic shuntsSelective shunts
• Select non-intestinal flow to
be shunted to the systemic
venous drainage while
leaving the intestinal venous
drainage to continue to pass
through the liver
• The most well known of this
type is the splenorenal
Ask the Experts Patient Education Program
Portosystemic shuntstransjugular intrahepatic portosystemic shunt
(TIPS)
• During the TIPS procedure, a radiologist makes a tunnel through the liver with a needle
• Connecting the portal vein (the vein that carries blood from the digestive organs to the liver) to one of the hepatic veins (the three veins that carry blood from the liver)
• A metal stent is placed in this tunnel to keep the tunnel open.
Ask the Experts Patient Education Program
More about the TIPS procedure
• The TIPS procedure reroutes blood flow in the liver and reduces pressure in all abnormal veins, not only in the stomach and esophagus, but also in the bowel and the liver
• The TIPS procedure is not a surgical procedure. The radiologist performs the procedure within the vessels under X-ray guidance
• The TIPS procedure controls bleeding immediately in over 90 percent of patients. However, in about 30 percent of patients, the shunt may narrow, causing varices to bleed again at a later time
Ask the Experts Patient Education Program
Ascites
• Abnormal collection of fluid in the abdomen, between the intestines and the skin
• This collection is a result of the water leaking out of the portal veins (because the high pressure)
Ask the Experts Patient Education Program
Treatment of ascites
• The management includes:
– Salt restriction in the diet
– Medications to increase the urination (diuretics), like spironolactone
– Paracentesis (drainage of the fluid with a needle)
– and transjugular intrahepatic portosystemic shunt (TIPS)
• This should be gradual to avoid sudden changes in systemic volume status which can precipitate hepatic encephalopathy, renal failure and death
Ask the Experts Patient Education Program
Hepatic encephalopathy
• Mental changes, usually confusion and forgetfulness caused by poor liver function
• One of the functions of the liver is to clean the blood from toxins (like ammonia) that comes from the intestines
Ask the Experts Patient Education Program
Treatment of Hepatic encephalopathy
• A treatment plan may involve:
– Lactulose
– Enemas
– and use of antibiotics (rifaximin, neomycin, vancomycin, and quinolones)
• Restriction of dietary protein was recommended but this is now refuted by multiple clinical trials which shows no benefit (only on few special circumstances)
• Instead, the maintenance of adequate nutrition is now advocated
Ask the Experts Patient Education Program
What Lifestyle Changes Should Be Made for Portal Hypertension?
• Maintaining good nutritional habits and keeping a healthy lifestyle may help you avoid portal hypertension
• Some of the things you can do to improve the function of your liver include the following:– Do not use alcohol or street drugs.– Do not take any over-the-counter or prescription drugs or
herbal medicines without first consulting your doctor or nurse
• Follow the dietary guidelines given by your health care provider, including: – Eating a low-sodium (salt) diet. You will probably be required to
consume no more than 2 grams of sodium per day. – Reduced protein intake may be required if confusion is a
symptom
Ask the Experts Patient Education Program
Thanks for coming and I am ready for all your questions!
Ask the Experts Patient Education Program
PEDIATRIC LIVER TRANSPLANTATION
Kadakkal Radhakrishnan,MD
Pediatric Hepatologist- Cleveland Clinic Children’s
Ask the Experts: Pediatric Liver Disease
Patient Education Program
Ask the Experts Patient Education Program
History of liver transplant
• 1st liver transplant by Dr. Thomas Starzl in 1963
• Now about 500 pediatric liver transplants– 12% of the total transplants
• Introduction of better immunosuppression has prolonged survival to almost 95% post liver transplant – Cyclosporine in 1980s
– Tacrolimus in 1990s
Ask the Experts Patient Education Program
Why would a child need liver transplant
• Acute Fulminant liver failure
• Progressive liver failure or dysfunction
– Cirrhosis and its related problems
– And worsening synthetic function
• Complications related to liver disease
• Liver transplant as a curative treatment for certain disorders
– Metabolic disorder like urea cycle disorder
Ask the Experts Patient Education Program
Indications for liver transplant
• 50% of pediatric transplants are due to Biliary Atresia
• Acute Liver failure
• Complications of long standing liver disease like autoimmune liver disease and Primary Sclerosing Cholangitis
• Genetic disorders -like Progressive Familial Intrahepatic Cholestasis
• Metabolic disorders
Ask the Experts Patient Education Program
Biliary Atresia
• Seen in new born babies-– All babies should have conjugated Bilirubin
measured after the first week of life
• The tube that drains bile to intestine- the bile duct become scarred
• This causes bile to accumulate in the liver and cause liver damage
• A surgery to open the bile duct in first 2 months of life will help with flow of duct
Ask the Experts Patient Education Program
Biliary Atresia
Normal anatomy Biliary Atresia
Ask the Experts Patient Education Program
Biliary Atresia-Kasai Surgery
Ask the Experts Patient Education Program
Once transplant is considered
• Patient and family will meet with a team of healthcare providers
• To evaluate whether the patient would be a candidate for transplant
Ask the Experts Patient Education Program
Once evaluation is completed
• Transplant labs are reviewed
• Evaluation details are discussed in the Liver Transplant Selection Committee and approved
• The details are then sent off to UNOS ( United Network of Organ Sharing) where the final listing is approved
Ask the Experts Patient Education Program
Listing process
• Patient are stratified for transplant based on accepted scoring norms
• Highest listing for patients in Acute Fulminant Liver failure
• Scores– PELD score for children under 12
– MELD score for over 12 years
– If children are sicker than what scores reflect, center may appeal for higher score
Ask the Experts Patient Education Program
After listing
• The wait begin
– 17% of children die waiting for liver transplant
• Should have an active phone contact
• Call can come any time
• Need to inform the transplant center with any change in health status, especially fever
• No live vaccines after listing
Ask the Experts Patient Education Program
Organ Sources
• Cadaveric– Often in children , a split liver or a piece of liver is
required
• Living donor– Again only a piece of the liver is removed
– Donor liver will regenerate back
– Donor undergoes rigorous evaluation by a separate team
Ask the Experts Patient Education Program
Human liver lobes
Ask the Experts Patient Education Program
Transplant Surgery
• Long process
– Can take up to 10 hours
• A team of surgeons and anesthesiologist will be involved
• For Living donor Transplants
– One to work on the donor and the other on the recipient
Ask the Experts Patient Education Program
Life after transplant
• Hospitalization for a few weeks- now about 2 weeks average
• Initially on many medication including rejection medicine – tacrolimus and
– Steroids weaned off by 3 months
• Labs frequently including Tacrolimus levels
• Drains removed after few days
• Oral diet started once bowels wake up
Ask the Experts Patient Education Program
Life after transplant
• Regular US to assess flow of through the liver
• Reality hits after discharge
• Life slowly returns to normal.
• Fevers not to be taken lightly because of immunosuppression- high risk for
– Bacterial infection initially
– Activation of certain viruses
• Request parents to call us ASAP with concerns
Ask the Experts Patient Education Program
Life after transplant
• School- can return after 3 months-
– I generally advise to wait till spring if transplanted in winter
• Some children need IEP or 528 plan
• Generally – no dietary restrictions except-
– Grape fruit can increase tacrolimus levels
• Need to worry about medication interaction especially with Erythromycin etc
Ask the Experts Patient Education Program
Vaccines after transplant
• NO LIVE VACCINES
• Other vaccines can be resumed after 3-6 months
• Flu vaccine can be given after 6 weeks
• Reach out to transplant/ infectious disease doctor if exposed to chicken pox, measles or any vaccine preventable disease
Ask the Experts Patient Education Program
Long term issues
• Kids can play sports- have to careful with enlarged spleen
• Need to watch kidney function and blood pressure
• Tacrolimus can increase cholesterol and therefore needs to be monitored when children get older
• Skin care- higher risk of skin cancer and there fore adequate sun protection
• Bone -adequate vitamin D
Ask the Experts Patient Education Program
Naim Alkhouri, MD
Director of the Metabolic Liver Disease. Cleveland Clinic
12/8/2016
Ask the Experts: Pediatric Liver Disease
Patient Education Program
Nonalcoholic Fatty Liver Disease
Ask the Experts Patient Education Program
Metabolic Syndrome
• Insulin Resistance
• Hyperlipidemia
• Hypertension
Obesity and Fatty Liver
NAFLD
Ask the Experts Patient Education Program
NAFLD Prevalence• Adults
– Overall: 30%
– Obese: 50-70%
– Severely Obese: 85%
– DM2: 65-75%
• Children
– Overall: 10%
– 15-19 years: 17%
– Obese: 50%
Obesity and Adipose Tissue
Ask the Experts Patient Education Program
SteatosisNASH/
Fibrosis Cirrhosis
Liver related morbidity and mortality
Simple Steatosis
(NAFL)
NASH/ FibrosisCirrhosis
10-20% 10-20%
Ask the Experts Patient Education Program
Young Kids, Old Bodies
Obesity is turning a generation of children into biological
adults, ageing them before their time
Ask the Experts Patient Education Program
Diagnosis of NAFLD
• Lack sensitivity
• Cannot distinguish between NAFL and NASH
Imaging Studies
US
Laboratory Tests
ALT & AST
Ask the Experts Patient Education Program
Liver Biopsy: Easier Said than Done
NAFLD affects 1/10 children
5 million American Children have NAFLD
5 million liver biopsies!!!!
Ask the Experts Patient Education Program
Staging the Severity of Fibrosis in NAFLD: VCTE
Actuator
Ask the Experts Patient Education Program
Shear Wave Movement
Controlled Frequency 50 Hz Shear Wave
Ask the Experts Patient Education Program
Controlled Attenuation Parameter (CAP)
• Estimate the ultrasound attenuation (forward and
return paths) at the frequency of 3.5 MHz.
• CAP values range from 100 to 400 dB/m
Ask the Experts Patient Education Program
Assessment of the Child with Suspected NAFLD
• 1. Rule out other etiologies for elevated liver enzymes/ fatty infiltration of the liver.
• 2. Evaluate for co-morbidities/ extra-hepatic manifestations of NAFLD.
• 3. Determine the severity of NAFLD – Presence of NASH
– Presence of liver fibrosis
Ask the Experts Patient Education Program
Not All Fatty Liver is NAFLD!
A
LAL
Deficiency
Ask the Experts Patient Education Program
Therapeutic ApproachMetabolic Syndrome
(MetS)
Yes No
Treat NAFLDTreat MetS
Insulin Sensitizers
Lipid Lowering
Anti-HTN
Weight
Exercise
Vitamin E
Enroll Trials
PHT
Screen for HCC
OLT
Steatosis NASH Cirrhosis
Ask the Experts Patient Education Program
Mediterranean Diet for NAFLDHIGH IN: LOW IN:
MUFA
PUFA
Folate
Fiber
Antioxidants
Saturated
Fat
Ask the Experts Patient Education Program
TONIC: Vitamin E or Metformin for Treatment of Pediatric NAFLD
Lavine JE, et al. JAMA. 2011;305:1659-1668.
Children aged
8 to 17 years
with NAFLD,
no diabetes or
cirrhosis
(N = 173)
Vitamin E
400 IU twice daily
(n = 58)
Metformin
50 mg twice daily
(n = 57)
Placebo
(n = 58)
Biopsy at Week 96Biopsy at Week 0
• Double-blind, placebo-controlled, randomized, multicenter Phase II trial
• 81% boys, 61% Hispanic, 42% with baseline NASH, mean BMI 34 kg/m2, mean baseline ALT 123 U/L
Ask the Experts Patient Education Program
NASH grade evolution (Brunt score)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Before After
3
2
1
0
11%
25.6%
63.4%
1.2%3.7%9.8%
85.4%
Comparison of NASH grade distrbution p<0.00001
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Before After
4
3
2
1
0
3.75%7.5%
21.25%
40%
27.5%
7.5%2.5%
13.75%
32.5%
43.75%
p<0.003
No NASH
NASH
NASH disappaerance
N= 82 patients with paired liver biopsies
Fibrosis Improvement
Fibrosis evolution
85% of NASH disappearance, 1 year after
Bariatric surgery
Effects of bariatric surgery on severe liver injury in morbidly obese patients with
proven NASH: a prospective study